CoChat

Cerebrospinal fluid β‐amyloid and phospho‐tau biomarker interactions affecting brain structure in preclinical Alzheimer disease

Fortea, Juan, Vilaplana, Eduard, Alcolea, Daniel, Carmona‐Iragui, María, Sánchez‐Saudinos, María‐Belén, Sala, Isabel, Antón‐Aguirre, Sofía, González, Sofía, Medrano, Santiago, Pegueroles, Jordi, Morenas, Estrella, Clarimón, Jordi, Blesa, Rafael, Lleó, Alberto, for the Alzheimer's Disease Neuroimaging Initiative · 2014 · Annals of Neurology
Cited by 143

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

Objective: To assess the relationships between core cerebrospinal fluid (CSF) biomarkers and cortical thickness (CTh) in preclinical Alzheimer disease (AD). Methods: In this cross‐sectional study, normal controls (n = 145) from the Alzheimer's Disease Neuroimaging Initiative underwent structural 3T magnetic resonance imaging (MRI) and lumbar puncture. CSF β‐amyloid 1–42 (Aβ) and phospho‐tau 181p (p‐tau) levels were measured by Luminex assays. Samples were dichotomized using published cutoffs (Aβ+/Aβ− and p‐tau+/ptau−). CTh was measured by Freesurfer. CTh difference maps were derived from interaction and correlation analyses. Clusters from the interaction analysis were isolated to analyze the directionality of the interaction by analysis of covariance. Results: We found a significant biomarker interaction between CSF Aβ and CSF p‐tau levels affecting brain structure. Cortical atrophy only occurs in subjects with both Aβ+ and p‐tau+. The stratified correlation analyses showed that the relationship between p‐tau and CTh is modified by Aβ status and the relationship between Aβ and CTh is modified by p‐tau status. p‐Tau–dependent thinning was found in different cortical regions in Aβ+ subjects but not in Aβ− subjects. Cortical thickening was related to decreasing CSF Aβ values in the absence of abnormal p‐tau, but no correlations were found in p‐tau+ subjects. Interpretation: Our data suggest that interactions between biomarkers in AD result in a 2‐phase phenomenon of pathological cortical thickening associated with low CSF Aβ, followed by atrophy once CSF p‐tau becomes abnormal. These interactions should be considered in clinical trials in preclinical AD, both when selecting patients and when using MRI as a surrogate marker of efficacy. Ann Neurol 2014;76:223–230

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.24186

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 143

Metadata

Authors
Fortea, J., Vilaplana, E., Alcolea, D., Carmona‐Iragui, M., Sánchez‐Saudinos, M., Sala, I., Antón‐Aguirre, S., González, S., Medrano, S., Pegueroles, J., Morenas, E., Clarimón, J., Blesa, R., Lleó, A., & Initiative, F. T. A. D. N.
Venue
Annals of Neurology
Publisher
Wiley
Published
2014-06-13
Volume
76
Issue
2
Pages
223-230
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W1836749191
Cited by
143
References
24
FWCI
7.41
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cerebrospinal fluid β‐amyloid and phospho‐tau biomarker interactions affecting brain structure in preclinical Alzheimer disease. https://app.cochat.ai/papers/10.1002/ana.24186
The paper
Fortea, J., Vilaplana, E., Alcolea, D., Carmona‐Iragui, M., Sánchez‐Saudinos, M., Sala, I., Antón‐Aguirre, S., González, S., Medrano, S., Pegueroles, J., Morenas, E., Clarimón, J., Blesa, R., Lleó, A., & Initiative, F. T. A. D. N. (2014). Cerebrospinal fluid β‐amyloid and phospho‐tau biomarker interactions affecting brain structure in preclinical Alzheimer disease. Annals of Neurology. https://doi.org/10.1002/ana.24186

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.